Oscar Health, Inc. $OSCR Stock Position Raised by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. increased its holdings in Oscar Health, Inc. by 3.7% during Q1, now owning nearly 7.86% of the company, valued at approximately $258.2 million.
• Multiple hedge funds, including Larson Financial Group and GAMMA Investing, significantly increased their stakes in Oscar Health, illustrating a growing interest from institutional investors.
• Several analysts have downgraded Oscar Health's stock, with a consensus rating of "Reduce" and a price target averaging $12.07, reflecting a bearish outlook.

Vanguard Group Inc. grew its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 3.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,698,442 shares of the company's stock after buying an additional 700,469 shares during the quarter. Vanguard Group Inc. owned approximately 7.86% of Oscar Health worth $258,247,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Southeastern Asset Management Inc. TN increased its stake in Oscar Health by 52.2% during the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after acquiring an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its holdings in shares of Oscar Health by 37.8% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after acquiring an additional 477,634 shares during the last quarter. Man Group plc lifted its stake in shares of Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after purchasing an additional 1,405,554 shares during the period. Victory Capital Management Inc. grew its stake in Oscar Health by 23.8% in the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after acquiring an additional 54,938 shares during the period. Finally, Toronto Dominion Bank acquired a new position in Oscar Health in the 4th quarter valued at $1,008,000. Institutional investors own 75.70% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. UBS Group restated a "sell" rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Piper Sandler decreased their price objective on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Robert W. Baird restated a "neutral" rating and issued a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Finally, Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, Oscar Health has an average rating of "Strong Sell" and an average price target of $12.07.

Oscar Health Stock Up 7.2%

Shares of OSCR stock traded up $1.1120 during trading hours on Friday, reaching $16.5320. The company had a trading volume of 12,416,047 shares, compared to its average volume of 13,563,624. The company has a market capitalization of $4.27 billion, a P/E ratio of -20.36 and a beta of 1.86. The stock's fifty day simple moving average is $16.06 and its 200 day simple moving average is $14.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm's quarterly revenue was up 29.0% compared to the same quarter last year. During the same period last year, the business posted $0.20 earnings per share. As a group, sell-side analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.